At 12-month follow-up , 8 of 115 patients in the dexamethasone group ( 7.0 % ) and 4 of 114 patients ( 3.5 % ) in the placebo group had POCD ( relative risk , 1.98 ; 95 % CI , 0.61 to 6.40 ; P = 0.24 ) .